Annual report pursuant to Section 13 and 15(d)

Note 12 - Segment Information - Financial Information Relating to Reportable Segments (Details)

v3.19.3
Note 12 - Segment Information - Financial Information Relating to Reportable Segments (Details) - USD ($)
 12 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2017
Revenues, net $ 714,006,000 $ 642,993,000 $ 563,003,000
Operating income 146,719,000 136,178,000 120,584,000
Costs recognized upon sale of acquired inventory (3,739,000) (2,455,000) (3,037,000)
Amortization of acquired intangible assets (58,550,000) (46,983,000) (44,393,000)
Restructuring costs (376,000)
Corporate general, selling and administrative expenses (264,359,000) (240,636,000) (200,443,000)
Net sales 714,006,000 642,993,000 563,003,000
United States and Canada 154,039,000 145,348,000  
Intangible assets, net 579,429,000 446,332,000 452,042,000
United States and Canada [Member]      
United States and Canada 138,016,000 129,360,000  
Intangible assets, net 556,951,000 417,430,000  
Europe [Member]      
United States and Canada 14,439,000 14,597,000  
Intangible assets, net 16,637,000 21,386,000  
Asia [Member]      
United States and Canada 1,584 1,391  
Intangible assets, net 5,841 7,516  
Consumables [Member]      
Revenues, net 588,979,000 534,738,000 476,541,000
Net sales 588,979,000 534,738,000 476,541,000
Protein Sciences [Member] | Consumables [Member]      
Revenues, net 430,655,000 384,350,000 341,611,000
Net sales 430,655,000 384,350,000 341,611,000
Diagnostics and Genomics [Member] | Consumables [Member]      
Revenues, net 158,324,000 150,388,000 134,930,000
Net sales 158,324,000 150,388,000 134,930,000
Operating Segments [Member]      
Operating income 250,998,000 245,376,000 213,386,000
Operating Segments [Member] | Protein Sciences [Member]      
Revenues, net 543,159,000 482,378,000 419,365,000
Operating income 240,919,000 209,880,000 184,095,000
Net sales 543,159,000 482,378,000 419,365,000
Operating Segments [Member] | Diagnostics and Genomics [Member]      
Revenues, net 171,674,000 161,151,000 143,742,000
Operating income 10,079,000 35,496,000 29,291,000
Net sales 171,674,000 161,151,000 143,742,000
Intersegment Eliminations [Member]      
Revenues, net (827,000) (536,000) (104,000)
Net sales (827,000) (536,000) (104,000)
Segment Reconciling Items [Member]      
Acquisition related expenses (2,282,000) (24,429,000) (25,789,000)
Stock-based compensation (33,057,000) (28,240,000) (14,631,000)
Corporate, Non-Segment [Member]      
Corporate general, selling and administrative expenses $ (6,651,000) $ (6,715,000) $ (4,952,000)